MedPath
HSA Approval

Olanzapine Mevon Film-coated Tablets 10 mg

SIN14228P

Olanzapine Mevon Film-coated Tablets 10 mg

Olanzapine Mevon Film-coated Tablets 10 mg

September 13, 2012

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N05AH03

olanzapine

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen S.A.

Active Ingredients

Olanzapine

10.00 mg

Olanzapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Olanzapine Mevon Film-coated Tablets 10 mg - HSA Approval | MedPath